En Colombia
Media & Internet · Colombia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
ColombiaPhone Number
+57 3112976079Website
www.encolombia.comRevenue
<$5 MillionIndustry
About En Colombia
Is En Colombia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if En Colombia has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if En Colombia had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if En Colombia is spiking on competitors!
Earning: See what the market has to say on En Colombia recently announced quarterly report
Funding: Get notified immidiatlly once En Colombia has new funding data
En Colombia, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at En Colombia
Product Launch: Get notified when En Colombia launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
En Colombia is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
En Colombia is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about En Colombia.
En Colombia Tech Stack
A closer look at the technologies used by En Colombia
Top Media & Internet Companies
Frequently Asked Questions Regarding En Colombia
En Colombia is a digital media platform that's been connecting people with information for over 20 years. They reach audiences across Latin America, the Caribbean, and the United States with a massive website that gets over 6 million monthly visitors. Half their content focuses on medical information for healthcare professionals, while the other ha... Read More